By Bruce Japsen and Sandra M. Jones | Walgreen Co. reversed a decision to carry genetic test kits in its stores after the U.S. Food and Drug Administration began looking into the supplier.
The Deerfield-based drugstore had planned to begin stocking its shelves with the Pathway Genomics home test kit on Friday, as reported by the Tribune yesterday. Walgreens’ decision was announced within hours after the FDA released an enforcement letter sent to San Diego-based Pathway giving it 15 days to respond to the agency’s request for information regarding its controversial genetic home test kit.
